However currently the role of OPG and its relationship with chronic inflammatory markers in T2D patients affecting by PAD remains unclear, largely unexplored in experimental and clinical investigations, considering that there are some frequently ignored aspects like polyvascular atherosclerosis which might influence OPG levels [19]. This evidence concerns the gene TNFRSF11B and atherosclerosis.